British Patient Capital invests in Ultraleap’s GBP60m funding round through Future Fund: Breakthrough
British Patient Capital has participated in Ultraleap’s Series D funding round which has closed at GBP60 million. The deal is one of the first investments from Future Fund: Breakthrough, a GBP375 million programme where British Patient Capital co-invests with private sector investors in later stage R&D-intensive UK companies. Ultraleap’s hand